Not Yet Recruiting
CYTALUX Dose Extension Study
NCT07469202
- Conditions
- Adnexal Diseases, Cancer in the Lung, Endocrine Gland Neoplasms, +19 more
- Locations
-
Not specified
Clinical trial condition
Endocrine Gland Neoplasms
Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.
6,086 public trials
1,368 recruiting studies
Endocrine Gland Neoplasms trial results
Not Yet Recruiting
Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
NCT07469956
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
Not Yet Recruiting
A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
NCT07462468
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
Not specified
NCT07465133
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Helios University Clinic Wuppertal, University Witten/Herdecke Wuppertal, North Rhine-Westphalia, Germany
Not Yet Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
NCT07459283
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
- Locations
-
- Affiliated Hospital of Jiangnan University Wuxi, Jiangsu, China
Not Yet Recruiting
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07454018
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
Not specified
Not Yet Recruiting
QLS5132 Combination Therapy in Advanced Solid Tumors
NCT07453394
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Bronchial Neoplasms, +34 more
- Locations
-
Not specified
Not Yet Recruiting
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
NCT07448376
- Conditions
- Borderline Resectable Pancreatic Cancer, CTCs, Digestive System Diseases, +18 more
- Locations
-
- Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China
NCT07446049
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
- Locations
-
Not specified
Not Yet Recruiting
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT07440290
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Birmingham Children's Hospital Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom